PubMed:27866394 / 1037-1183 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T8","span":{"begin":0,"end":146},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":146},"obj":"Sentence"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}

{"project":"LitCoin-entities","denotations":[{"id":"11774","span":{"begin":49,"end":51},"obj":"GeneOrGeneProduct"},{"id":"11775","span":{"begin":54,"end":58},"obj":"GeneOrGeneProduct"},{"id":"11776","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"},{"id":"11777","span":{"begin":68,"end":71},"obj":"GeneOrGeneProduct"},{"id":"11778","span":{"begin":78,"end":83},"obj":"GeneOrGeneProduct"},{"id":"11779","span":{"begin":126,"end":130},"obj":"GeneOrGeneProduct"},{"id":"11780","span":{"begin":137,"end":142},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A22","pred":"db_id","subj":"11774","obj":"NCBIGene:24806"},{"id":"A23","pred":"db_id","subj":"11775","obj":"NCBIGene:24807"},{"id":"A24","pred":"db_id","subj":"11776","obj":"NCBIGene:24598"},{"id":"A25","pred":"db_id","subj":"11777","obj":"NCBIGene:117064"},{"id":"A26","pred":"db_id","subj":"11778","obj":"NCBIGene:25742"},{"id":"A27","pred":"db_id","subj":"11779","obj":"NCBIGene:24241"},{"id":"A28","pred":"db_id","subj":"11780","obj":"NCBIGene:58959"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}

{"project":"LitCoin-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":146},"obj":"Sentence"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T11","span":{"begin":54,"end":58},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":78,"end":82},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":126,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":137,"end":142},"obj":"GeneOrGeneProduct"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T6","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":78,"end":82},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":126,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":137,"end":142},"obj":"GeneOrGeneProduct"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T3","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":78,"end":82},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":126,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":137,"end":142},"obj":"GeneOrGeneProduct"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T13","span":{"begin":68,"end":71},"obj":"ChemicalEntity"}],"attributes":[{"id":"A13","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T13","span":{"begin":68,"end":71},"obj":"ChemicalEntity"},{"id":"T81166","span":{"begin":137,"end":142},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":126,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T95090","span":{"begin":78,"end":82},"obj":"GeneOrGeneProduct"},{"id":"T57900","span":{"begin":61,"end":65},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A13","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"}],"text":"In particular, the drug prevents the decrease in SP-, NK1r-, nNOS-, VIP-, and S100β-immunoreactivity (IR) and the increase in CGRP-, and CRF1r-IR."}